Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-7,429
Closed -$241K 504
2017
Q1
$241K Sell
7,429
-795
-10% -$25.1K 0.03% 403
2016
Q4
$253K Buy
+8,224
New +$251K 0.04% 398
2016
Q3
Sell
-7,772
Closed -$260K 515
2016
Q2
$260K Buy
+7,772
New +$248K 0.04% 390
2014
Q4
Sell
-17,103
Closed -$480K 513
2014
Q3
$480K Buy
+17,103
New +$480K 0.1% 93

Other funds holding PFE

Parkwood LLC's PFE Position: Q2 2017 in Review

Parkwood LLC sold out of Pfizer (PFE) in Q2 2017, closing a stake of 7,429 shares — an estimated $241K sold.

Parkwood LLC first reported a position in PFE in Q3 2014 and held it in 4 quarters. The position peaked at $480K in Q3 2014. 2,050 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

  • Parkwood LLC reported no remaining Pfizer position as of Q2 2017 after selling out during the quarter.
  • Parkwood LLC sold 7,429 Pfizer shares in Q2 2017, an estimated $241K.
  • Parkwood LLC first reported a position in Pfizer in Q3 2014 and held it in 4 quarters.
  • Parkwood LLC's Pfizer position peaked at $480K in Q3 2014.
  • 2,050 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Parkwood LLC's 13F filing for Q2 2017, filed 25 Jul 2017.